Vivani Medical director buys 793,650 shares

Vivani Medical, Inc. director and 10% owner Gregg Williams reported buying 793,650 shares of common stock in a private sale at $1.26 per share, as disclosed in an August 11, 2025 Share Purchase Agreement.

Rhea-AI Filing Summary

Vivani Medical, Inc. director and 10% owner Gregg Williams reported buying 793,650 shares of common stock in a private sale at $1.26 per share, as disclosed in an August 11, 2025 Share Purchase Agreement. The gross proceeds for this private sale transaction were $999,999.00. Following the purchase, he beneficially owns 41,711,936 shares directly and through several trusts and LLCs, and has voting and dispositive power over all of these shares.

Insider Trade Summary

Net Buyer: 793,650 shares

Net Buy 2 txns

Insider Williams Gregg

Role Director, 10% Owner

Bought 793,650 shs ($1000K)

Type	Security	Shares	Price	Value
Purchase	Common Stock F1, F2	793,650	$1.26	$1000K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 36,912,736 shares (Indirect, See footnote); Common Stock — 4,799,200 shares (Direct)

Footnotes (2)

1. F1. The reporting person purchased 793,650 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of August 11, 2025 at a price of $1.26 per share, which was the last reported sale price of the Issuer's common stock on the Nasdaq on August 10, 2025 (the day immediately prior to August 11, 2025). The gross proceeds from this private sale transaction were $999,999.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote.
2. F2. The reporting person owns 41,711,936 shares directly and/or indirectly as follows: (i) 4,799,200 shares of common stock owned by the reporting person, (ii) 34,786,984 shares of common stock owned by Gregg G. Williams 2006 Trust, (iii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iv) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (v) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.

Key Figures

Shares purchased: 793,650 shares Purchase price: $1.26 per share Gross proceeds: $999,999.00 +3 more

6 metrics

Shares purchased 793,650 shares Common Stock private sale transaction reported on 2026-07-15

Purchase price $1.26 per share Price under Share Purchase Agreement dated August 11, 2025

Gross proceeds $999,999.00 Gross proceeds for the private sale transaction as described in the footnote

Direct holdings after transaction 4,799,200 shares Common Stock held directly by Gregg Williams

Indirect holdings after transaction 36,912,736 shares Common Stock held through trusts and LLCs associated with Gregg Williams

Total beneficial ownership 41,711,936 shares Common Stock owned directly and indirectly with voting and dispositive power

Key Terms

open-market purchase, Share Purchase Agreement, voting and dispositive power, Generation-Skipping Trust

4 terms

open-market purchase financial

"Transaction code "P" denotes a purchase in open market or private transaction"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

Share Purchase Agreement regulatory

"disclosed in the Share Purchase Agreement dated as of August 11, 2025"

A share purchase agreement is a written contract that outlines the terms and conditions for buying and selling shares of a company. It specifies details like the price, number of shares, and any special conditions, ensuring both buyer and seller agree on the transaction. For investors, it provides clarity and legal protection, making sure the purchase is clear and enforceable.

voting and dispositive power financial

"Gregg Williams has voting and dispositive power over all of these shares"

Generation-Skipping Trust regulatory

"Sam B. Williams 1995 Generation-Skipping Trust"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Gregg Williams report in Vivani Medical (VANI)?

Gregg Williams reported purchasing 793,650 shares of Vivani Medical common stock. The shares were acquired in a private sale at $1.26 per share under a Share Purchase Agreement dated August 11, 2025, tied to the last reported Nasdaq sale price on August 10, 2025.

At what price and total value did the Vivani Medical (VANI) insider purchase occur?

The insider purchase was executed at $1.26 per share for 793,650 shares. A related footnote states that the gross proceeds for this private sale transaction were $999,999.00, based on the last reported sale price on Nasdaq the prior trading day.

How many Vivani Medical (VANI) shares does Gregg Williams own after this transaction?

After the reported purchase, Gregg Williams beneficially owns 41,711,936 Vivani Medical shares. This total includes shares he holds directly and shares held through multiple trusts and LLCs over which he has voting and dispositive power.

How are Gregg Williams' Vivani Medical (VANI) holdings split between direct and indirect ownership?

Gregg Williams holds 4,799,200 Vivani Medical shares directly. Indirectly, he controls 34,786,984 shares via the Gregg G. Williams 2006 Trust and 2,125,752 shares through several LLCs and another trust, totaling 36,912,736 indirectly held shares.

Does Gregg Williams have voting control over his Vivani Medical (VANI) shares?

Yes. A footnote explains that Gregg Williams has voting and dispositive power over all 41,711,936 Vivani Medical shares he owns directly and indirectly. This includes shares held in the named trusts and LLCs associated with him.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/16/2026 - 09:00 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Williams Gregg

(Last) (First) (Middle)

C/O VIVANI MEDICAL, INC.

1350 S. LOOP ROAD

(Street)

ALAMEDA CALIFORNIA 94502

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vivani Medical, Inc. [ VANI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/15/2026		P(1)		793,650	A	$1.26	36,912,736	I	See footnote(2)
Common Stock								4,799,200	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person purchased 793,650 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of August 11, 2025 at a price of $1.26 per share, which was the last reported sale price of the Issuer's common stock on the Nasdaq on August 10, 2025 (the day immediately prior to August 11, 2025). The gross proceeds from this private sale transaction were $999,999.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote.

2. The reporting person owns 41,711,936 shares directly and/or indirectly as follows: (i) 4,799,200 shares of common stock owned by the reporting person, (ii) 34,786,984 shares of common stock owned by Gregg G. Williams 2006 Trust, (iii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iv) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (v) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.

	/s/ Anthony Baldor, Attorney-in-fact	07/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)